SML0050
CGP 37849
≥98% (HPLC)
Synonym(s):
(3E)-2-Amino-4-methyl-5-phosphono-3-pentanoic acid
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C6H12NO5P
CAS Number:
Molecular Weight:
209.14
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Quality Level
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
H2O: ≥2 mg/mL (warmed)
storage temp.
2-8°C
SMILES string
C\C(CP(O)(O)=O)=C/C(N)C(O)=O
InChI
1S/C6H12NO5P/c1-4(3-13(10,11)12)2-5(7)6(8)9/h2,5H,3,7H2,1H3,(H,8,9)(H2,10,11,12)/b4-2+
InChI key
BDYHNCZIGYIOGJ-DUXPYHPUSA-N
Application
CGP 37849 may be used in NMDA-mediated cell signaling studies.
Biochem/physiol Actions
CGP 37849 induces phencyclidine-like behavioral syndrome in amygdala-kindled rats that includes ataxia, locomotion and stereotypies.
CGP 37849 is a potent orally active competitive NMDA antagonist and anticonvulsant.
Potent orally active competitive NMDA antagonist and anticonvulsant.
Still not finding the right product?
Explore all of our products under CGP 37849
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Janel M Boyce-Rustay et al.
Synapse (New York, N.Y.), 56(4), 222-225 (2005-04-02)
The present study examined the roles of NR2A and NR2B subunit-containing NMDA receptors in the mediation of the sedative/hypnotic effects of ethanol in mice. The ability of the competitive NMDA antagonist, CGP-37849 (0, 1, or 3 mg/kg), and the NR2B-selective
W Löscher et al.
The Journal of pharmacology and experimental therapeutics, 257(3), 1146-1153 (1991-06-01)
The novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist DL-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid (CGP 37849) was found to produce a phencyclidine (PCP)-like behavioral syndrome (ataxia, locomotion, stereotypies) in amygdala-kindled rats, whereas the amphetamine-like behavioral alterations of the syndrome (locomotion, stereotypies) were only infrequently seen
Romana Slamberová et al.
European journal of pharmacology, 516(1), 10-17 (2005-05-21)
Epileptic afterdischarges elicited by stimulation of sensorimotor cortex were chosen to test anticonvulsant effects of NMDA receptor antagonists in developing rats (12, 18 and 25 days old) with implanted electrodes. Afterdischarges were elicited four times with 10-min intervals in the
Global Trade Item Number
| SKU | GTIN |
|---|---|
| SML0050-25MG | 04061832074665 |
| SML0050-5MG | 04061832074672 |